Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch1 of Acetylcysteine Injection, 6 gm/30 mL ...

Glenmark Pharma, an India-based drug manufacturer that has been the focal point of a spate of recalls in recent years, has ...

Glenmark Pharmaceuticals Inc. USA has acquired and launched Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) ...

Glenmark Pharmaceuticals is recalling around 14.76 lakh bottles of Atomoxetine Capsules due to detected CGMP deviations and ...

This new product will be available in the strength of 6 gm/30 mL (200 mg/mL) single-dose vials in the US market, marking an ...

Glenmark Pharmaceuticals has launched injection Acetylcysteine in the US after acquiring its abbreviated new drug application ...

Glenmark Pharmaceuticals Ltd is quoting at Rs 1380.8, up 3.49% on the day as on 12:49 IST on the NSE. The stock is up 49.05% in last one year as compared to a 0.46% fall in NIFTY and a 4.57% fall in ...

Glenmark’s Acetylcysteine Injection (DEL) is approved based on the safety and efficacy derived from the reference drug ...

Mahwah: Glenmark Pharmaceuticals Inc., USA has announced the launch of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) ...

AM(IST)on Wednesday in an upbeat market. Glenmark Pharmaceuticals Ltd.(up 3.06 per cent), Aurobindo Pharma Ltd.(up 2.91 per ...

Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on ...